Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye

被引：0

作者：

Seung Min Lee ^{[1
,2
]}

Jae Woo Jung ^{[1
,2
]}

Sung Who Park ^{[2
,3
]}

Ji Eun Lee ^{[2
,3
]}

Ik Soo Byon ^{[1
,2
]}

机构：

[1] Research Institute for Convergence of Biomedical Science and Technology,Pusan National University Yangsan Hospital

[2] Department of Ophthalmology,College of Medicine,Pusan National University

[3] Biomedical Research Institute,Pusan National University Hospital

来源：

International Journal of Ophthalmology | 2017年 / 06期

关键词：

ME; Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye;

D O I：

暂无

中图分类号：

R779.6 [眼外科手术学];

学科分类号：

100212 ;

摘要：

Dear Editor,Ozurdex;（Allergan,Inc,Irvine,CA,USA）is a sustainedrelease dexamethasone implant and is an approved therapy for several types of macular edema（ME）and for treatment of inflammation associated with non-infectious uveitis.Common adverse effects from Ozurdex;insertion include increased intraocular pressure and cataract progression;;however other ocular complications,such as

引用

页码：1019 / 1020

页数：2

共 50 条

[1] Retinal injury following intravitreal injection of a dexamethasone implant in a vitrectomized eye
Lee, Seung Min
Jung, Jae Woo
Park, Sung Who
Lee, Ji Eun
Byon, Ik Soo
[J]. INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2017, 10 (06) : 1019 - 1020
[2] Retinal injury following intravitreal injection of a dexamethasone implant in a non-vitrectimised eye
Jain, M. Arvind
Khanna, Amishi
Narendran, V.
[J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2020, 68 (06) : 1178 - 1178
[3] Retina Injury After Dexamethasone Injection Into a Vitrectomized Eye
Elliott, Michael S.
Montezuma, Sandra R.
[J]. JOURNAL OF VITREORETINAL DISEASES, 2020, 4 (06) : 538 - 540
[4] Resolution of Persistent Cystoid Macular Edema due to Central Retinal Vein Occlusion in a Vitrectomized Eye following Intravitreal Implant of Dexamethasone 0.7 mg
Reibaldi, Michele
Russo, Andrea
Zagari, Marco
Toro, Mario
De Grande, Vittorio
Cifalino, Valentina
Rametta, Stefania
Faro, Salvatore
Longo, Antonio
[J]. CASE REPORTS IN OPHTHALMOLOGY, 2012, 3 (01): : 30 - 34
[5] Retinal and vitreous hemorrhage after traumatic impact of dexamethasone implant in a vitrectomized eye
Casati, Stefano
Bruni, Enrico
Marchini, Giorgio
[J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (03) : E55 - E57
[6] Commentary: Endophthalmitis following intravitreal injection of dexamethasone implant
Rishi, Ekta
Manchegowda, Pradeep T.
[J]. INDIAN JOURNAL OF OPHTHALMOLOGY, 2019, 67 (03) : 426 - 428
[7] Treatment of postoperative cystoid macular oedema with dexamethasone intravitreal implant in a vitrectomized eye - a case report
Merkoudis, Nikolaos
Granstam, Elisabet
[J]. ACTA OPHTHALMOLOGICA, 2013, 91 (03) : E238 - E239
[8] Comment to: Retinal and vitreous hemorrhage after traumatic impact of dexamethasone implant in a vitrectomized eye
Panjaphongse, Ronakorn
Stewart, Jay M.
[J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (04) : E87 - E87
[9] Acute retinal necrosis following intravitreal dexamethasone (Ozurdex®) implant
Kucukevcilioglu, Murat
Eren, Mustafa
Yolcu, Umit
Sobaci, Gungor
[J]. ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2015, 78 (02) : 118 - 119
[10] Periorbital Necrotizing Fasciitis Following Dexamethasone Intravitreal Implant Injection
Danan, Jeremy
Heitz, Antoine
Bourcier, Tristan
[J]. JAMA OPHTHALMOLOGY, 2016, 134 (01) : 110 - 111

← 1 2 3 4 5 →